Correlation Between Samsung Biologics and QUALITAS SEMICONDUCTOR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and QUALITAS SEMICONDUCTOR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and QUALITAS SEMICONDUCTOR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Biologics Co and QUALITAS SEMICONDUCTOR LTD, you can compare the effects of market volatilities on Samsung Biologics and QUALITAS SEMICONDUCTOR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of QUALITAS SEMICONDUCTOR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and QUALITAS SEMICONDUCTOR.

Diversification Opportunities for Samsung Biologics and QUALITAS SEMICONDUCTOR

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Samsung and QUALITAS is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and QUALITAS SEMICONDUCTOR LTD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QUALITAS SEMICONDUCTOR and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with QUALITAS SEMICONDUCTOR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QUALITAS SEMICONDUCTOR has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and QUALITAS SEMICONDUCTOR go up and down completely randomly.

Pair Corralation between Samsung Biologics and QUALITAS SEMICONDUCTOR

Assuming the 90 days trading horizon Samsung Biologics is expected to generate 7.63 times less return on investment than QUALITAS SEMICONDUCTOR. But when comparing it to its historical volatility, Samsung Biologics Co is 3.35 times less risky than QUALITAS SEMICONDUCTOR. It trades about 0.01 of its potential returns per unit of risk. QUALITAS SEMICONDUCTOR LTD is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,019,000  in QUALITAS SEMICONDUCTOR LTD on October 21, 2024 and sell it today you would lose (24,000) from holding QUALITAS SEMICONDUCTOR LTD or give up 2.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Samsung Biologics Co  vs.  QUALITAS SEMICONDUCTOR LTD

 Performance 
       Timeline  
Samsung Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Samsung Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
QUALITAS SEMICONDUCTOR 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in QUALITAS SEMICONDUCTOR LTD are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, QUALITAS SEMICONDUCTOR is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Samsung Biologics and QUALITAS SEMICONDUCTOR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Samsung Biologics and QUALITAS SEMICONDUCTOR

The main advantage of trading using opposite Samsung Biologics and QUALITAS SEMICONDUCTOR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, QUALITAS SEMICONDUCTOR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in QUALITAS SEMICONDUCTOR will offset losses from the drop in QUALITAS SEMICONDUCTOR's long position.
The idea behind Samsung Biologics Co and QUALITAS SEMICONDUCTOR LTD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance